文献速递肺血管病与心包/心肌炎

MDM2介导的ACE2泛素化促进肺动脉高压发生

MDM2-Mediated Ubiquitination of Angiotensin-Converting Enzyme 2 Contributes to the Development of Pulmonary Arterial Hypertension.
PubMed 文献 · Circulation · 2020-07-28

研究探讨MDM2是否通过泛素化ACE2参与肺动脉高压(PH)发病,以及AMPK与MDM2的交互作用。生物信息学、内皮细胞、小鼠模型及特发性肺动脉高压患者标本显示,MDM2升高、ACE2降低;抑制MDM2可逆转小鼠实验性PH。ACE2 Ser-680磷酸化与Lys-788泛素化修饰失衡参与PH发病,联合干预AMPK与MDM2可能成为PH治疗策略。

要点

  • MDM2升高、ACE2降低见于特发性肺动脉高压患者及实验性PH动物模型。
  • MDM2抑制剂JNJ-165可逆转C57BL/6小鼠SU5416/缺氧诱导的PH。
  • ACE2 Ser-680去磷酸化增加PH易感性,Lys-788去泛素化可减轻实验性PH。

核心结论

  • ACE2在Ser-680的磷酸化与Lys-788的泛素化等翻译后修饰失衡参与肺动脉高压及实验性PH的发病。
  • 肺内皮中联合干预AMPK与MDM2可能对PH治疗有效。

研究设计与样本

  • 采用生物信息学分析探索泛素化ACE2的E3连接酶。
  • 使用培养内皮细胞、小鼠模型及特发性肺动脉高压患者标本研究AMPK与MDM2在PH背景下对ACE2磷酸化与泛素化的调控。

主要发现

  • 特发性肺动脉高压患者及实验性PH啮齿动物模型的肺组织或肺动脉内皮细胞中MDM2水平升高、ACE2水平降低。
  • JNJ-165抑制MDM2可逆转C57BL/6小鼠SU5416/缺氧诱导的PH。
  • ACE2-S680L小鼠(S680去磷酸化)表现出PH易感性,异位表达ACE2-S680L/K788R(K788去泛素化)可减轻实验性PH。
  • 在内皮细胞特异性AMPKα2敲除小鼠中过表达ACE2-K788R可缓解PH。

临床怎么用

  • MDM2抑制在实验性PH中显示逆转作用,提示其作为治疗靶点的潜在价值。
  • 肺内皮AMPK与MDM2联合干预可能成为PH治疗方向,尚需临床研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Angiotensin-converting enzyme 2 (ACE2) converts angiotensin II, a potent vasoconstrictor, to angiotensin-(1-7) and is also a membrane protein that enables coronavirus disease 2019 (COVID-19) infectivity. AMP-activated protein kinase (AMPK) phosphorylation of ACE2 enhances ACE2 stability. This mode of posttranslational modification of ACE2 in vascular endothelial cells is causative of a pulmonary hypertension (PH)-protective phenotype. The oncoprotein MDM2 (murine double minute 2) is an E3 ligase that ubiquitinates its substrates to cause their degradation. In this study, we investigated whether MDM2 is involved in the posttranslational modification of ACE2 through its ubiquitination of ACE2, and whether an AMPK and MDM2 crosstalk regulates the pathogenesis of PH. METHODS: Bioinformatic analyses were used to explore E3 ligase that ubiquitinates ACE2. Cultured endothelial cells, mouse models, and specimens from patients with idiopathic pulmonary arterial hypertension were used to investigate the crosstalk between AMPK and MDM2 in regulating ACE2 phosphorylation and ubiquitination in the context of PH. RESULTS: Levels of MDM2 were increased and those of ACE2 decreased in lung tissues or pulmonary arterial endothelial cells from patients with idiopathic pulmonary arterial hypertension and rodent models of experimental PH. MDM2 inhibition by JNJ-165 reversed the SU5416/hypoxia-induced PH in C57BL/6 mice. ACE2-S680L mice (dephosphorylation at S680) showed PH susceptibility, and ectopic expression of ACE2-S680L/K788R (deubiquitination at K788) reduced experimental PH. Moreover, ACE2-K788R overexpression in mice with endothelial cell-specific AMPKα2 knockout mitigated PH. CONCLUSIONS: Maladapted posttranslational modification (phosphorylation and ubiquitination) of ACE2 at Ser-680 and Lys-788 is involved in the pathogenesis of pulmonary arterial hypertension and experimental PH. Thus, a combined intervention of AMPK and MDM2 in the pulmonary endothelium might be therapeutically effective in PH treatment.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Shen H, Zhang J, Wang C, et al. MDM2-Mediated Ubiquitination of Angiotensin-Converting Enzyme 2 Contributes to the Development of Pulmonary Arterial Hypertension. Circulation. 2020. PMID: 32755395. doi:10.1161/CIRCULATIONAHA.120.048191

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。